Loading companies…
Italy · Healthtech · AI
Holifya is a digital clinic for obesity and metabolic health that combines physician-supervised care with nutrition and behavioral support. Clinicians assess each patient and may prescribe GLP-1/GIP medicines when medically appropriate; the medication sits within an ongoing programme of personalized eating, activity and follow-up rather than being dispensed as a standalone product.
Patients begin with a medical consultation and assessment. A care team then builds a personalized programme that can include clinical monitoring, nutrition and lifestyle guidance, and follow-up support. If a doctor determines that it is appropriate, GLP-1 or GIP medication may be prescribed; patients obtain prescribed medicines from a pharmacy, and treatment remains supervised by the clinician.
Holifya combines digital access to consultations and care with advanced diagnostics and ongoing patient follow-up. Its role is to coordinate a treatment pathway and support adherence, not simply sell a weight-loss drug or provide an unsupervised diet plan.
The clinic serves people seeking a medically guided approach to obesity and metabolic health, including patients who may be eligible for pharmacological treatment. Holifya is a live digital-care provider in Italy; its September 2026 financing is intended to support growth of the service and its technology.
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Funding | €2M | 20Fund — ParticipantCDP Venture Capital — ParticipantDoorway — ParticipantDuccio Vitali — ParticipantMatteo Mainetti — ParticipantMicol Fornaroli — ParticipantNext Age — ParticipantPier Francesco Rimbotti — ParticipantTommaso Gamaleri — ParticipantZooga VC — Participant |